Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis

International Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 1, 2008, Pages 60-65

  Vairaktaris, E ^a   Kalokerinos, G ^a   Goutzanis, L ^a   Yapijakis, C ^a   Derka, S ^a   Vassiliou, S ^a   Spyridonidou, S ^a   Vylliotis, A ^a   Nkenke, E ^b   Lazaris, A ^a   Patsouris, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bax; Bcl 2; histological grade; immunohistochemistry; Ki 67; oral cancer

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MOUTH CARCINOMA; MOUTH MUCOSA; NONHUMAN; ORAL BIOPSY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 36849085418     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2007.06.012     Document Type: Article

References (27)

1. Carson D.A., and Ribeiro J.M. Apoptosis and disease. Lancet 341 (1993) 1251-1254
2. Derka S., Vairaktaris E., Papakosta V., Vassiliou S., Acil Y., Vylliotis A., Spyridonidou S., Lazaris A.C., Mourouzis C., Kokkori A., Moulavassili P., Perrea D., Donta I., Yapijakis C., and Patsouris E. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncol 42 (2006) 540-550
3. Fan T.J., Han L.H., Cong R.S., and Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin 37 (2005) 719-727
4. Fan T.J., Xia L., and Han Y.R. Mitochondrion and apoptosis. Sheng Wu Hua Xue Yu Acta Biochim Biophys Sin 33 (2001) 7-12
5. Finney L.S., Finney M.O., and Gonzales Campoy J.M. What the mouth has to say about diabetes. Careful examinations can avert serious complications. Postgrad Med 102 (1997) 117-126
6. Fisher W.E., Muscarella P., Boros L.G., and Schirmer W.J. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse. Surgery 123 (1998) 315-320
7. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 386 (2005) 193-205
8. Glickman J. Clinical Periodontology (1972), Saunders, Philadelphia
9. Goutzanis L., Vairaktaris E., Yapijakis C., Kavantzas N., Nkenke E., Derka S., Vassiliou S., Acil Y., Kessler P., Stavrianeas N., Perrea D., Donta I., Skandalakis P., and Patsouris E. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43 (2007) 165-173
10. Junod A., Lambert A.E., Stauffacher W., and Renold A.E. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48 (1969) 2129-2139
11. Kawamura M., Fukuda S., Kawabata K., and Iwamoto Y. Comparison of health behaviour and oral/medical conditions in non-insulin-dependent (type 2) diabetics and non diabetics. Aust Dent J 43 (1998) 315-320
12. Liu S.C., and Klein-Szanto A.J.P. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 36 (2000) 145-151
13. Loro L.L., Johannessen A.C., and Vintermyr O.K. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations. J Clin Pathol 58 (2005) 1157-1162
14. Loro L.L., Vintermyr O.K., Liavaag P.G., Jonsson R., and Johannessen A.C. Oral squamous cell carcinoma is associated with decreased Bcl-2/Bax expression ratio and increased apoptosis. Hum Pathol 30 (1999) 1097-1105
15. Lu C.X., Fan T.J., Hu G.B., and Cong R.S. Apoptosis-inducing factor and apoptosis. Acta Biochim Biophys Sin 35 (2003) 881-885
16. Magrath I., and Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 85 (1993) 862-874
17. Matsumoto M., Komiyama K., Okaue M., Shimoyama Y., Iwakami K., Namaki S., Tanaka H., Moro I., and Sato H. Predicting tumour metastasis in patients with oral cancer by means of the proliferation marker Ki-67. J Oral Sci 41 (1999) 53-56
18. Ogawa W., Matozaki T., and Kasuga M. Role of binding proteins to IRS-1 in insulin signalling. Mol Cell Biochem 182 (1998) 13-22
19. Ribeiro D.A., Salvadori D.M., and Marques M.E. Abnormal expression of Bcl-2 and Bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Int J Exp Pathol 86 (2005) 375-381
20. Schoelch M.L., Regezi J.A., Dekker N.P., Ng I.O., McMillan A., Ziober B.L., Le Q.T., Silverman S., and Fu K.K. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35 (1999) 333-342
21. Tumuluri V., Thomas G.A., and Fraser I.S. Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med 31 (2002) 598-604
22. Ujpal M., Matos O., Bibok G., Somogyi A., Szabo G., and Suba Z. Diabetes and oral tumors in Hungary. Epidemiological correlations. Diabetes Care 27 (2004) 770-774
23. Ujpal M., Matos O., Bibok G., and Szabo G. Incidence of diabetes mellitus in patients with malignant tumors of the oral cavity. Orv Hetil 143 (2002) 2731-2733
24. Williams H.K. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 53 (2000) 165-172
25. Wyllie A.H. The genetic regulation of apoptosis. Curr Opin Genet Dev 5 (1995) 97-104
26. Xi S., and GRandis J.R. Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82 (2003) 11-16
27. Xie X., De Angelis P., Clausen O.P.F., and Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86 (1999) 913-920